Ileostomy Market Size and Share

Ileostomy Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Ileostomy Market Analysis by Mordor Intelligence

The ileostomy market stood at USD 1.31 billion in 2025 and is predicted to reach USD 1.86 billion by 2030, advancing at a 7.30% CAGR. The expansion stems from three converging forces: an ageing population with higher inflammatory bowel disease (IBD) incidence, steady colorectal-cancer surgery volumes, and rapid product innovation in two-piece drainable systems. North America remains the largest regional contributor, while Asia-Pacific registers the quickest uptake thanks to hospital-capacity upgrades and growing life expectancy. Procedure patterns are also evolving; surgeons now favour temporary loop ileostomies for bowel preservation, yet permanent end procedures still dominate volumes. Competitive intensity is moderate as leading firms differentiate through digital leakage alerts, mouldable skin barriers, and service-backed care ecosystems.

Key Report Takeaways

  • By procedure type, end ileostomy led with 62.54% of ileostomy market share in 2024, whereas loop ileostomy is forecast to post a 7.81% CAGR through 2030. 
  • By system type, two-piece products captured 58.27% of the ileostomy market in 2024; one-piece solutions are projected to expand at 8.05% CAGR to 2030. 
  • By equipment, stoma bags accounted for 76.31% of the ileostomy market size in 2024; accessories and others segment is set to grow at 8.12% CAGR during 2025-2030. 
  • By disease, cancer contributed 42.93% revenue share in 2024, while Crohn’s disease is advancing at 8.95% CAGR to 2030. 
  • By end user, hospitals held 51.25% share of the ileostomy market size in 2024, and home care is projected to rise at 8.49% CAGR over the forecast period. 
  • By geography, North America commanded 43.28% share of the ileostomy market in 2024; Asia-Pacific is the fastest-growing region at 8.84% CAGR to 2030.

Segment Analysis

By Procedure Type – End Procedures Dominate but Loop Demand Accelerates

End ileostomy accounted for 62.54% of 2024 revenue, anchoring the ileostomy market with long-term users whose appliance lifespan can exceed a decade. Post-operative complexity and higher stoma output push hospitals to select durable two-piece barriers with reinforced hydrocolloid bases. The competing loop segment, though smaller, posts a 7.81% CAGR as surgeons increasingly construct temporary diversions for low-anterior resections. Quality-improvement projects prove that timely reversal trims 30-day readmissions from 20.10% to 8.75%. Manufacturers therefore design lightweight, skin-gentle systems that simplify changes during the short active period.

The loop surge expands the ileostomy market by recruiting younger patients who value ease of removal before re-anastomosis. Educational apps guide them through emptying schedules, output tracking, and early warning signs. Combined with nurse-led tele-follow-ups, these tools cut emergency visits and reinforce brand loyalty. Consequently, procedure-specific kits with pre-cut sizing and colour-coded panels are gaining traction among colorectal centres.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Equipment Type – Stoma Bags Retain Core Value While Accessories Flourish

Stoma bags represented 76.31% of 2024 revenue, confirming their central role in the ileostomy market. High demand persists for drainable pouches with integrated filter membranes that mitigate ballooning and odour. Yet accessories and others segment races ahead at 8.12% CAGR, propelled by barrier wipes, adjustable belts, and deodorising gels. Clinicians now deploy malodour-reducing additives that lower odour intensity scores and enhance social confidence.

Risk-stratified protocols limit peristomal skin complications to 6.2% by 90 days when advanced barrier rings and convex cushions are combined with structured teaching. This evidence encourages suppliers to bundle pouches with accessory starter packs, embedding long-term usage habits and elevating average selling price. The growing accessory mix further diversifies revenue streams within the ileostomy market.

By Disease Type – Cancer Still Leads as IBD Drives Future Growth

Cancer surgeries captured 42.93% of 2024 sales, anchoring the ileostomy market in oncology wards. Nonetheless, Crohn’s disease delivers the steepest 8.95% CAGR as chronic relapses mandate repeat surgeries and possible permanent diversion. Fecal calprotectin measurement from stoma effluent offers a non-invasive biomarker for flare monitoring. Product designers now integrate sampling ports that allow clinicians to collect effluent without detaching pouches, easing disease surveillance.

Regional epidemiology reinforces the trend. India is projected to witness disproportionate IBD prevalence growth by 2050. Consequently, suppliers are tailoring high-output pouches with extended-wear taps that connect to bedside collectors, addressing unpredictable drainage patterns typical of severe Crohn’s. These disease-specific advances preserve momentum in the ileostomy market

By System Type – Two-Piece Flexibility Versus One-Piece Simplicity

Two-piece systems owned 58.27% of 2024 revenue, reflecting user preference for changing bags without disturbing the skin barrier, an essential feature in high-output scenarios. Improved coupling clicks and tactile feedback reassure visually impaired or elderly wearers. Conversely, the one-piece category logs an 8.05% CAGR as adhesive science and flexible wafers reduce leakage anxiety. Surveys confirm mouldable one-piece products now rival two-piece for wear-time while simplifying morning routines.

Continuous product education underpins better outcomes; an AAH white paper links correct system choice with up to 40% fewer peristomal complications. As differentiation narrows, firms add QR-code videos and multilingual guides to drive proper fitting. Both system types thus sustain parallel growth corridors, expanding the overall ileostomy market size for system innovators.

By Usability – Drainable Bags Prevail yet Closed-End Niches Rise

Drainable options dominated 68.43% of 2024 expenditure, meeting the clinical reality of liquid output. Soft-tap extensions now attach directly to bed-side containers, reducing nocturnal emptying for hospitalised patients and freeing nursing time. Closed-end bags, though smaller, rise at 8.27% CAGR, serving travel, sports, and intimate-activity niches where single-use discretion outweighs cost.

Selective continence devices such as internal plugs yield 67.4% continence and 74.9% quality-of-life gains. Producers therefore invest in hybrid bags that toggle between drainable and closed-end modes, merging convenience with environmental waste reduction goals. This dual-design trend underlines how usability features fuel continuous differentiation within the ileostomy market.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By End User – Care Shifts from Inpatient to Home

Hospitals held 51.25% revenue share in 2024, but policymakers worldwide now promote same-day colorectal surgery and tele-follow-up, favouring home-based recovery. The home-care channel hence climbs at 8.49% CAGR as families assume daily stoma management. Early rehabilitation programmes help 72% of working-age patients return to employment within six months when supported by interdisciplinary teams.

App-linked reorder reminders and subscription deliveries reduce supply lapses, further entrenching home care growth. Ambulatory surgical centres, with lean cost structures, expand ostomy volume too, especially for elective loop closures. Collectively, shifting sites of service recalibrate demand patterns, stimulating fresh go-to-market models in the ileostomy industry.

Geography Analysis

North America generated 43.28% of 2024 revenue, cementing its leadership through specialist nursing density, widespread insurance coverage, and rapid adoption of digital leakage monitors. FDA alignment with ISO 13485 in 2025 ensures smoother premarket submissions, fostering swift technological upgrades. Despite laparoscopic uptake tempering new stoma creation, premium upselling offsets volume softness, keeping the ileostomy market size resilient.

Asia-Pacific remains the quickest climber with an 8.84% CAGR to 2030. Urban hospitals in China and India now stock convex-fit barriers and adjustable belts, reflecting higher disposable incomes. China’s health-spend trajectory towards USD 33.4 trillion by 2060 reinforces structural demand for chronic-care devices. Emerging reimbursement pilots in Thailand and Indonesia further unlock access, although rural distribution gaps persist.

Europe presents a mature yet innovation-minded landscape. The EU Packaging and Packaging Waste Regulation forces all medical packaging to be recyclable by 2030. Producers have responded with thinner, mono-material pouches that sustain barrier properties while cutting plastic weight. Simultaneously, single-use-device reprocessing rules guide safe recycling of support belts and closure clips. These regulatory nudges drive sustainable product redesign within the ileostomy market.

Ileostomy Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

Coloplast, ConvaTec, and Hollister collectively anchor the competitive field, each backing flagship launches with educational platforms. Coloplast advanced digital sensing through Heylo, offering real-time leakage alerts via smartphones. Hollister reinforced high-output management with integrated soft-tap pouches for critical-care settings.

Mid-tier firms B. Braun and 3M sharpen differentiation on region-specific lines such as Flexima Active for Asian users needing slimmer profiles. The FDA’s predetermined change-control plans enacted in 2024 streamline iterative upgrades, incentivising rapid material tweaks without fresh regulatory dossiers [3]Federal Register, “FDA Quality System Regulation Amendments,” federalregister.gov. Competitive focus has therefore shifted from price to lifetime episode cost, with vendors bundling tele-nurse support, skin-monitoring apps, and replenishment logistics into subscription models.

White-space opportunities persist in paediatric stomas, personalised 3-D printed barriers, and AI-powered wearables predicting effluent pH shifts before leakage. Start-ups collaborating with university additive-manufacturing labs can now prototype customised flanges within 24 hours, trimming fitting appointments and hospital revisits. As digital ecosystems mature, future winners in the ileostomy market will likely marry physical devices with data-driven service layers that guarantee outcome-based contracting to payers.

Ileostomy Industry Leaders

  1. ConvaTec Inc.

  2. B. Braun Melsungen AG

  3. Coloplast

  4. Hollister Incorporated

  5. Salts Healthcare

  6. *Disclaimer: Major Players sorted in no particular order
Ileostomy Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • July 2024: Coloplast unveiled Heylo, the first digital leakage notification system for stoma users, integrating embedded sensors and a mobile application to alert wearers before breakthrough leakage events.
  • May 2024: Coloplast broadened its ostomy portfolio by launching Heylo, SenSura Mio Black, and SenSura Mio Convex Soft with Flex coupling to enhance fit choice and consumer aesthetics.

Table of Contents for Ileostomy Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising prevalence of inflammatory bowel disease (IBD)
    • 4.2.2 Growing colorectal-cancer surgical incidence
    • 4.2.3 Ageing population & chronic disease burden
    • 4.2.4 Advances in two-piece drainable bags
    • 4.2.5 Emergence of digital stoma-monitoring wearables
    • 4.2.6 Adoption of 3-D printed custom-fit skin barriers
  • 4.3 Market Restraints
    • 4.3.1 Shift toward minimally-invasive bowel-sparing procedures
    • 4.3.2 Cost & reimbursement gaps in developing economies
    • 4.3.3 Supply-chain vulnerability of hydrocolloid adhesives
    • 4.3.4 Waste-disposal regulations for single-use ostomy products
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts

  • 5.1 By Procedure Type
    • 5.1.1 End Ileostomy
    • 5.1.2 Loop Ileostomy
  • 5.2 By Equipment Type
    • 5.2.1 Stoma Bags
    • 5.2.2 Belts & Girdles
    • 5.2.3 Accessories & Others
  • 5.3 By Disease Type
    • 5.3.1 Cancer
    • 5.3.2 Crohn’s Disease
    • 5.3.3 Ulcerative Colitis
    • 5.3.4 Other Indications
  • 5.4 By System Type
    • 5.4.1 One-Piece Systems
    • 5.4.2 Two-Piece Systems
  • 5.5 By Usability
    • 5.5.1 Drainable Bags
    • 5.5.2 Closed-End Bags
  • 5.6 By End User
    • 5.6.1 Hospitals
    • 5.6.2 Home-care Settings
    • 5.6.3 Ambulatory Surgical Centers
  • 5.7 By Geography
    • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
    • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
    • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 Japan
    • 5.7.3.3 India
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
    • 5.7.4 Middle East & Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East & Africa
    • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Coloplast A/S
    • 6.3.2 ConvaTec Group Plc
    • 6.3.3 Hollister Incorporated
    • 6.3.4 B. Braun Melsungen AG
    • 6.3.5 3M Healthcare
    • 6.3.6 Salts Healthcare Ltd
    • 6.3.7 Flexicare Medical Ltd
    • 6.3.8 Marlen Manufacturing & Development
    • 6.3.9 Smith & Nephew Plc
    • 6.3.10 Welland Medical Ltd
    • 6.3.11 Nu-Hope Laboratories Inc.
    • 6.3.12 Cymed Micro Skin
    • 6.3.13 ALCARE Co., Ltd.
    • 6.3.14 Medline Industries LP
    • 6.3.15 Torbot Group Inc.
    • 6.3.16 Trio Healthcare
    • 6.3.17 Safe N Simple LLC
    • 6.3.18 Fittleworth Medical Ltd
    • 6.3.19 SecuriCare (Medical) Ltd
    • 6.3.20 Stomocare International

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

Our study defines the ileostomy market as the global sales of single-use or reusable collected-waste systems, bags, skin barriers, belts, pastes, and ancillary accessories used after surgically bringing the ileum to the abdominal surface, whether the stoma is temporary or permanent.

Scope exclusion: Devices meant strictly for colostomy or urostomy procedures are outside our baseline.

Segmentation Overview

  • By Procedure Type
    • End Ileostomy
    • Loop Ileostomy
  • By Equipment Type
    • Stoma Bags
    • Belts & Girdles
    • Accessories & Others
  • By Disease Type
    • Cancer
    • Crohn’s Disease
    • Ulcerative Colitis
    • Other Indications
  • By System Type
    • One-Piece Systems
    • Two-Piece Systems
  • By Usability
    • Drainable Bags
    • Closed-End Bags
  • By End User
    • Hospitals
    • Home-care Settings
    • Ambulatory Surgical Centers
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

Mordor analysts next interview colorectal surgeons, stoma nurses, procurement heads at hospitals, and home-care distributors across North America, Europe, Asia-Pacific, and the GCC to sense-check adoption curves, average selling prices (ASP), and accessory attachment rates, and to validate early desk assumptions that seemed volatile.

Desk Research

We start by mapping patient pools and surgery volumes from open datasets such as GLOBOCAN cancer registries, WHO IBD prevalence files, OECD hospital-discharge statistics, and U.S. Medicare HCPCS reimbursement logs. We then layer insights from national ostomy associations and peer-reviewed journals on stoma care. Company 10-Ks, FDA 510(k) summaries, and Dow Jones Factiva news help us refine launch timelines and price corridors. D&B Hoovers provides revenue splits that anchor vendor roll-ups. This list is illustrative; many more public and subscription sources underpin the desk phase.

Market-Sizing & Forecasting

A top-down prevalence-to-treated-cohort model converts incident colorectal-cancer and severe IBD cases into ileostomy procedures, adjusts for reversal rates and mortality, and multiplies by device usage norms. Supplier roll-ups and sampled ASP × volume checks provide a bottom-up lens for reconciliation before the totals are finalized. Key drivers baked into the model include: 1) elective colorectal-surgery backlog clearance, 2) shift toward two-piece drainable systems, 3) home-care penetration, 4) regional ASP erosion, and 5) aging population elasticity. A multivariate regression on these variables, inflation-adjusted, generates the 2025-2030 curve, with scenario analysis used to stress adverse reimbursement shocks. Gap pockets in bottom-up estimates are bridged through regional weighting based on import shipment data.

Data Validation & Update Cycle

Outputs undergo three-stage peer review, variance flags trigger secondary calls, and any material regulatory or recall event prompts an interim refresh. Reports are rebuilt annually, and we perform a last-minute sweep before client delivery.

Why Mordor's Ileostomy Baseline Earns Decision-Maker Confidence

Published estimates diverge because firms vary stoma-type scope, bundle accessories differently, and apply unlike ASP progressions.

Key gap drivers include: some sources merge colostomy with ileostomy revenues, others apply uniform global prices, or use historic procedure rates without discounting reversals. Our analysts, by contrast, isolate ileostomy-only devices, apply region-specific ASP ladders validated each quarter, and refresh patient pools annually.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 1.31 B (2025) Mordor Intelligence -
USD 1.20 B (2024) Global Consultancy A Merges ostomy sub-types; static ASP; two-year refresh cycle
USD 2.05 B (2025) Industry Association B Counts accessories sold for colostomy; assumes uniform device replacement interval

The comparison shows that when scope creep and dated inputs are stripped away, Mordor offers a balanced, transparent baseline that executives can retrace to discrete variables and repeatable steps, giving them greater confidence for planning and investment.

Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Ileostomy Market size?

The Ileostomy Market is projected to register a CAGR of 7.3% during the forecast period (2025-2030)

Who are the key players in Ileostomy Market?

ConvaTec Inc., B. Braun Melsungen AG, Coloplast, Hollister Incorporated and Salts Healthcare are the major companies operating in the Ileostomy Market.

Which is the fastest growing region in Ileostomy Market?

Asia-Pacific is projected to register the quickest 8.84% CAGR, driven by expanding hospital capacity and population ageing

Which region has the biggest share in Ileostomy Market?

In 2025, the North America accounts for the largest market share in Ileostomy Market.

What are the main restraints on market growth?

Minimally invasive bowel-sparing surgeries reduce ostomy creation in developed countries, and reimbursement gaps in developing economies limit premium product uptake.

Page last updated on:

Ileostomy Market Report Snapshots